CUSIP: 69329YAG9
What is CUSIP 69329YAG9?
CUSIP 69329YAG9 identifies 69329YAG9 - PDL BIOPHARMA INC - NOTE 2.750%12/0 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 69329YAG9:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2021 Q4 | $0 | $0 | -$3,827,000 | 0 | |
| 2021 Q3 | $103,000 | $3,827,000 | -$46,000 | 101.89% | 3 |
| 2021 Q2 | $121,463 | $3,873,000 | +$3,873,000 | 175.52% | 4 |
| 2020 Q4 | $0 | $0 | -$2,131,773 | 0 | |
| 2020 Q3 | $1,967,000 | $2,131,773 | -$11,410,618 | 108.25% | 2 |
| 2020 Q2 | $12,788,008 | $13,526,027 | -$57,694 | 105.88% | 7 |
| 2020 Q1 | $12,843,008 | $13,491,162 | -$4,769,773 | 105.64% | 6 |
| 2019 Q4 | $17,317,008 | $18,625,937 | -$43,441,512 | 108.41% | 9 |
| 2019 Q3 | $48,086,008 | $59,673,741 | -$88,793,113 | 96.16% | 14 |
| 2019 Q2 | $135,457,008 | $157,195,011 | +$1,224,555 | 105.08% | 20 |
| 2019 Q1 | $133,565,937 | $168,955,531 | +$2,455,120 | 114.59% | 20 |
| 2018 Q4 | $130,902,000 | $146,767,691 | +$768,520 | 101.27% | 19 |
| 2018 Q3 | $151,116,000 | $148,906,844 | -$2,304,211 | 98.68% | 20 |
| 2018 Q2 | $145,958,000 | $134,132,691 | -$1,368,947 | 91.84% | 17 |
| 2018 Q1 | $146,947,000 | $150,014,000 | +$1,924,254 | 101.91% | 18 |
| 2017 Q4 | $145,161,000 | $140,958,000 | +$2,213,559 | 97.4% | 20 |
| 2017 Q3 | $129,337,000 | $140,495,000 | +$11,520,239 | 108.53% | 18 |
| 2017 Q2 | $120,237,000 | $108,382,000 | -$360,497 | 90.01% | 16 |
| 2017 Q1 | $121,617,000 | $106,291,000 | -$10,248,641 | 87.31% | 16 |
| 2016 Q4 | $133,524,000 | $107,954,000 | +$107,954,000 | 80.82% | 16 |